[Therapy of degenerative maculopathy with Cosaldon A + E].

Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative maculopathy are presented (5 tables and 4 figures). Depending on the initial status up to 80% of the treated eyes responded positively to this therapy with only a small side-effect rate: these results suggest that Cosaldon A + E is a promising alternative in the treatment of degenerative maculopathy.